Homology-feature-assisted quantification of fibrotic lesions in computed tomography images: a proof of concept for CT image feature-based prediction for gene-expression-distribution - Scorecard - MDSpire
Advertisement
Homology-feature-assisted quantification of fibrotic lesions in computed tomography images: a proof of concept for CT image feature-based prediction for gene-expression-distribution
Clinical Scorecard: Feature-based Analysis of Fibrotic Lesions in CT Imaging: A Conceptual Study on Predicting Gene Expression Distribution
At a Glance
Category
Detail
Condition
Idiopathic interstitial pneumonia (IIP), including idiopathic pulmonary fibrosis (IPF)
Key Mechanisms
Quantification of fibrotic lesions in HRCT images using homology-based features (HFs) derived from Betti numbers (b0 and b1) via the homology-profile (HP) method
Target Population
Patients with idiopathic interstitial pneumonia and COVID-19 cases exhibiting fibrotic lung lesions
Care Setting
Radiology and diagnostic imaging settings utilizing high-resolution computed tomography (HRCT)
Key Highlights
IIP includes several categories with varying prognosis; IPF has the poorest prognosis and high mortality with acute exacerbations.
HRCT imaging is standard for diagnosing IIPs but has limitations due to inter-observer variability and difficulty in accurate classification.
The HP method quantifies fibrotic lesions by calculating Betti numbers representing connectivity and holes in CT image binary segments, potentially improving diagnostic accuracy.
Guideline-Based Recommendations
Diagnosis
Use HRCT imaging to identify typical fibrotic patterns such as traction bronchiectasis and honeycomb lung indicative of IPF.
Apply homology-profile (HP) method to HRCT images to quantify fibrotic lesions by analyzing connectivity features (Betti numbers).
Consider standardized thresholding between −700 to −400 HU for binarization in HP analysis.
Management
Recognize the poor prognosis of IPF and the importance of accurate diagnosis to guide treatment strategies.
Use quantitative imaging features to assist in differentiating fibrotic lesions from other lung abnormalities.
Monitoring & Follow-up
Monitor fibrotic lesion progression using serial HRCT imaging and homology-based feature mapping to assess changes in lesion connectivity and morphology.
Risks
Inter-observer variability in HRCT interpretation may lead to diagnostic inaccuracies.
Presence of interstitial lung abnormalities (ILAs) and lung cancer lesions can confound fibrotic lesion quantification.
Patient & Prescribing Data
Patients with idiopathic interstitial pneumonia and COVID-19 exhibiting fibrotic lung lesions
Quantitative imaging biomarkers derived from HP method may support clinical decision-making but no direct treatment data provided.
Clinical Best Practices
Employ HRCT imaging with standardized protocols for lung field extraction and image preprocessing.
Utilize homology-profile method with validated tile size (32×32 pixels) and shifting (8 pixels) for detailed fibrotic lesion mapping.
Exclude lung cancer lesions and obvious lung abnormalities when analyzing fibrotic lesions to reduce noise in quantification.